Literature DB >> 16412566

Functional polymorphism 57Val>Ile of aurora kinase A associated with increased risk of gastric cancer progression.

Hyoungseok Ju1, Hyunmi Cho, Yong Sung Kim, Woo Ho Kim, Chunhwa Ihm, Seung-Moo Noh, Jin-Bok Kim, Dong-Soo Hahn, Bo-Yuol Choi, Changwon Kang.   

Abstract

Overexpression or amplification of the aurora kinase A (AURKA) gene induces chromosomal instability and transformation. AURKA SNPs are associated with several human cancers but their association with gastric cancer has yet to be investigated. In this study, 501 gastric cancer patients and 427 controls were genotyped for two coding SNPs in AURKA, 91A>T (31Ile>Phe) and 169G>A (57Val>Ile). Allele or genotype association with gastric cancer susceptibility was not observed in comparisons between the patient and control samples. However, 169G/G genotype was significantly more frequent in advanced gastric cancers than in early gastric cancers (age/sex-adjusted OR=2.2, 95% CI=1.3-3.8, P=0.0042). Moreover, the elevated risk of gastric cancer progression was associated with 91T-169G (age/sex-adjusted OR=1.9, 95% CI=1.1-3.4, P=0.025) and 91A-169G (age/sex-adjusted OR=1.6, 95% CI=1.0-2.6, P=0.048) haplotypes, having approximately 2.5-fold higher kinase activity than 91T-169A haplotype. The results suggest that 169G>A in AURKA is associated with progression of gastric cancer by affecting relative kinase activities of AURKA variants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412566     DOI: 10.1016/j.canlet.2005.11.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jun Qin; Xiao-Feng He; Wu Wei; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Hui-Qiang Si
Journal:  Mol Genet Genomics       Date:  2014-08-26       Impact factor: 3.291

2.  Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.

Authors:  Andrea Necchi; Giulia Pintarelli; Daniele Raggi; Patrizia Giannatempo; Francesca Colombo
Journal:  Invest New Drugs       Date:  2017-02-03       Impact factor: 3.850

3.  Expansive marker analysis replicating the association of glaucoma susceptibility with human chromosome loci 1q43 and 10p12.31.

Authors:  Kyunglan Kim; Dong Won Heo; Sewon Kim; Jong-Sung Kim; Chang-sik Kim; Changwon Kang
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

Review 4.  Current and future trials of targeted therapies in cutaneous melanoma.

Authors:  Matthew S Evans; Subbarao V Madhunapantula; Gavin P Robertson; Joseph J Drabick
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms.

Authors:  Neal Jetton; Karen G Rothberg; James G Hubbard; John Wise; Yan Li; Haydn L Ball; Larry Ruben
Journal:  Mol Microbiol       Date:  2009-03-06       Impact factor: 3.501

Review 6.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 7.  Aurora kinase A in gastrointestinal cancers: time to target.

Authors:  Ahmed Katsha; Abbes Belkhiri; Laura Goff; Wael El-Rifai
Journal:  Mol Cancer       Date:  2015-05-20       Impact factor: 27.401

8.  Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.

Authors:  Weifeng Tang; Hao Qiu; Hao Ding; Bin Sun; Lixin Wang; Jun Yin; Haiyong Gu
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

9.  Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.

Authors:  Weifeng Tang; Hao Qiu; Heping Jiang; Lixin Wang; Bin Sun; Haiyong Gu
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Serine/threonine kinase 15 gene polymorphism and risk of digestive system cancers: A meta-analysis.

Authors:  Jianfei Luo; Ruicheng Yan; Li Zou
Journal:  Exp Ther Med       Date:  2014-11-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.